AI assistant
Sending…
Phathom Pharmaceuticals, Inc. — Director's Dealing 2024
Dec 20, 2024
32407_dirs_2024-12-20_9892cf38-478d-49fa-ab02-cc96083701d5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Phathom Pharmaceuticals, Inc. (PHAT)
CIK: 0001783183
Period of Report: 2024-12-19
Reporting Person: Nabulsi Azmi (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-12-19 | Common Stock | S | 1118 | $8 | Disposed | 239303 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 3578.93 | Indirect |
| Common Stock | 785700 | Indirect |
Footnotes
F1: Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units.
More from Phathom Pharmaceuticals, Inc.
Regulatory Filings
2026
May 21
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Regulatory Filings
2026
Mar 27
Director's Dealing
2026
Mar 3
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Feb 12